ESMO 2025 special: Prof. Tagawa presents the PSMAddition trial results
About this episode
In this episode, Prof. Scott Tagawa (US), a medical oncologist at Weill Cornell Medicine in New York, discusses the results of PSMAddition - a phase III trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.
This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on prostate cancer, please visit our educational platform UROONCO PCa.
For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
Get every episode summarized
Each time EAU Podcasts publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from EAU Podcasts
EAUN edition - No place to go: Homelessness & Incontinence
EAU Podcasts
EAU Section of Genitourinary Reconstructive Surgeons: Management of short bulbar...
EAU Podcasts
History Office: Ongoing discoveries from the life of Joaquín Albarrán (1860-1912...
EAU Podcasts
PEACE 2 results: Evaluating pelvic RT for very high-risk PCa
EAU Podcasts